BULLETIN V2026-2563
NUREXONE BIOLOGIC INC. ("NRX")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: August 6, 2026
TSX Venture Tier 2 Company
Financing Type: Non-Brokered Private Placement
Gross Proceeds: $627,795.26
Offering: 1,012,573 Listed Shares with 1,012,573 warrants attached
Offering Price: $0.62 per Listed Share
Warrant Exercise Terms: $0.78 per Listed Share for a 3-year period, subject to an acceleration right
Commissions in Securities:
N/A
Disclosure: Refer to the company's news release dated June 30, 2026.
_______________________________________
|
|
